![]() |
Joele Frank handles Mallinckrodt as it merges with Endo to create a global diversified pharmaceuticals company in a deal valued at $6.7B.
Mallinckrodt shareholders will own 50.1 percent of the revamped company with Endo stockholders getting a 49.9 percent stake.
Siggi Olafsson, Mallinckrodt, will become president & CEO, with Paul Efron, Endo director, taking the chairman slot.
The merger “will create a larger and more diversified entity with the scale and resources to unlock the full potential of both companies,” said Olafsson.
The combined company is expected to generate 2025 revenues of $3.6B and have about 5,700 employees.
Mallinckrodt’s Dublin headquarters will serve as the global HQ of the merged companies. A US headquarters, as well as a corporate name for the combined company, has yet to be determined.
Joele Frank, Wilkinson Brimmer Katcher has partners Michael Freitag, Aura Reinhard, and Aaron Palash; and directors Catherine Simon and Carly King handling Mallinckrodt.


Joele Frank handles Pine Gate Renewables as the Asheville, NC-based solar power development company declares Chapter 11 in the aftermath of Donald Trump’s cuts to wind & solar tax credits.
Stagwell CEO Mark Penn reports Q3 net revenues jumped 6 percent to $614.5M, a record performance for a non-political period. Operating income soared 45.7 percent to $60.9M.
Joele Frank works for Klöckner Pentaplast as the German maker of plastic films declares Chapter 11. A successful reorganization would slash its its corporate debt by $1.5B.
Teneo represents Metsera, the New York City biotech focused on weight-control products, which is subject to a bidding war between heavyweights Novo Nordisk and Pfizer.
Haggie Partners is working the $7B takeover of the specialty insurer Convex by Canada’s Onex private equity fund and American International Group.



